157 related articles for article (PubMed ID: 27128909)
1. Plasma Lipoprotein-Associated Phospholipase A₂ Levels Correlated with the Cardio-Ankle Vascular Index in Long-Term Type 2 Diabetes Mellitus Patients.
Kotani K
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128909
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
[TBL] [Abstract][Full Text] [Related]
3. Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.
Constantinides A; van Pelt LJ; van Leeuwen JJ; de Vries R; Tio RA; van der Horst IC; Sluiter WJ; Dullaart RP
Eur J Clin Invest; 2011 Aug; 41(8):820-7. PubMed ID: 21281278
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.
Nelson TL; Kamineni A; Psaty B; Cushman M; Jenny NS; Hokanson J; Furberg C; Mukamal KJ
Diabetologia; 2011 Feb; 54(2):329-33. PubMed ID: 21103980
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.
Gong HP; Du YM; Zhong LN; Dong ZQ; Wang X; Mao YJ; Lu QH
Lipids Health Dis; 2011 Jan; 10():13. PubMed ID: 21247435
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.
Garg S; Madhu SV; Suneja S
Indian J Med Res; 2015 Jan; 141(1):107-14. PubMed ID: 25857502
[TBL] [Abstract][Full Text] [Related]
7. The correlation between lipoprotein associated phospholipase A
Chen YH; Li WC; Chen YC; Yeh WC; Yu W; Hung HY; Jie XX; Chen JY
Int J Immunopathol Pharmacol; 2021; 35():20587384211048562. PubMed ID: 34796753
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment.
Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M
Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631
[TBL] [Abstract][Full Text] [Related]
10. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects.
Wang H; Liu J; Zhao H; Fu X; Shang G; Zhou Y; Yu X; Zhao X; Wang G; Shi H
J Am Soc Hypertens; 2013; 7(6):426-31. PubMed ID: 23871571
[TBL] [Abstract][Full Text] [Related]
11. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
Noto H; Chitkara P; Raskin P
J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
[TBL] [Abstract][Full Text] [Related]
12. Role of vitamin D in risk factors of patients with type 2 diabetes mellitus.
Zhang Q; Wu Y; Lu Y; Fei X
Med Clin (Barc); 2020 Mar; 154(5):151-156. PubMed ID: 31255367
[TBL] [Abstract][Full Text] [Related]
13. The effects of severe periodontitis on arterial stiffness using cardio-ankle vascular index in patients with type 2 diabetes.
Torumtay Cin G; Fenkci SM; Kiliç ID; Aslan HS; Sevgican Cİ; Şenol H
J Periodontal Res; 2024 Feb; 59(1):74-83. PubMed ID: 37909328
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A₂ mass level is increased in elderly subjects with type 2 diabetes mellitus.
Fortunato J; Bláha V; Bis J; Št'ásek J; Andrýs C; Vojáček J; Jurašková B; Sobotka L; Polanský P; Brtko M
J Diabetes Res; 2014; 2014():278063. PubMed ID: 24818163
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A
Lin XH; Xu MT; Tang JY; Mai LF; Wang XY; Ren M; Yan L
Lipids Health Dis; 2016 Nov; 15(1):203. PubMed ID: 27881128
[TBL] [Abstract][Full Text] [Related]
17. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
[TBL] [Abstract][Full Text] [Related]
18. [Effects of age on the relationship between cardio-ankle vascular index and atherosclerotic progression in patients with type 2 diabetes mellitus].
Wakabayashi I; Masuda H
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):217-21. PubMed ID: 16683656
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein-associated phospholipase A₂ activity predicts progression of subclinical coronary atherosclerosis.
Kinney GL; Snell-Bergeon JK; Maahs DM; Eckel RH; Ehrlich J; Rewers M; Hokanson JE
Diabetes Technol Ther; 2011 Mar; 13(3):381-7. PubMed ID: 21291330
[TBL] [Abstract][Full Text] [Related]
20. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
